Small · 2011 · 35 citations · 51 references
PharmacyBiotechnologyGene DeliveryGene TherapyStem Cell BiologyCell DeliveryGene Delivery SystemsGene Delivery To Stem CellsGene Delivery VectorsMesenchymal Stem Cell TherapyStem Cell Gene TherapyBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsGene Delivery BiomaterialsMesenchymal Stem Cell Gene TransferNonviral Gene Delivery VectorsNonviral VectorsPolysaccharide BiomaterialsTransfection Efficiency
This study investigates the use of a natural polysaccharide isolated from mulberry leaves as a nonviral gene vector. Ethylenediamine is chemically grafted to the backbone of a polysaccharide from mulberry leaves (MPS) to acquire nucleic acid binding affinity. A particle-size observation indicates that the cationic mulberry leaf polysaccharide (CMPS) can efficiently combine with plasmid transforming growth factor β1 (TGF-β1) to form nanoscaled particles. In addition, the electrophoresis assay indicates a retarded plasmid migration when the CMPS/pTGF-β1 weight ratio is increased to 30:1. The in vitro cell transfection experiment is performed based on bone marrow mesenchymal stem cells (MSCs) derived from rat femurs and tibias, and the findings reveal that the complex with a CMPS/pTGF-β1 weight ratio of 50:1 exhibits the highest cell transfection effect, which is significantly higher than that of branched poly(ethyleneimine) (PEI) (25 kDa; p = 0.001, Student's t-test) and slightly higher than Lipofectamine 2000. Moreover, the cytotoxicity assay also demonstrates that all of these tested complexes and the plasmid TGF-β1 are nontoxic to mesenchymal stem cells (MSCs). The results of the living cell imaging confirm that more of the CMPS/plasmid TGF-β1 nanoparticles can be taken up and at a faster rate by the MSCs than by the positive control Lipofectamine 2000; these data are consistent with the transfection efficiency data. Together, these results suggest that the CMPS/pTGF-β1 nanoparticle can potentially be developed into a promising alternative for the transfer of therapeutic genes into cells.
51
Carbohydrate analysis by a phenol–sulfuric acid method in microplate format
Tatsuya Masuko, Akio Minami, Norimasa Iwasaki et al. · Analytical Biochemistry · 2004 · 2.3K citations
Pharmacy, Biochemistry, Chemistry +13
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Mark H. Tuszynski, Leon J. Thal, Mary Pay et al. · Nature Medicine · 2005 · 1K citations
Medicine, Neurology, Neuroscience +17
Magnus Köping‐Höggård, Ioannis Tubulekas, Haitao Guan et al. · Gene Therapy · 2001 · 529 citations